Drugs Made In America Acquisition Corp. (DMAAR) Assets Average (2025 - 2026)

Drugs Made In America Acquisition (DMAAR) has reported Assets Average for 2 consecutive years, with $193.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 17.35% year-over-year to $193.4 million; the trailing twelve-month figure through Jun 2026 stood at $193.4 million (down 17.35% YoY), and the FY2025 full-year result was $120.2 million, changed N/A from the prior year.
• Assets Average retreated to $193.4 million in Q2 2026 per DMAAR's latest filing, from $238.8 million in the prior quarter.
• Across five years, Assets Average topped out at $238.8 million in Q4 2025 and bottomed at $116.7 million in Q1 2025.